Development of a functional backbone cyclic mimetic of the HIV-1 Tat arginine-rich motif
about
Peptides that bind the HIV-1 integrase and modulate its enzymatic activity--kinetic studies and mode of actionCharacterization and in vitro activity of a branched peptide boronic acid that interacts with HIV-1 RRE RNASynthesis of chemically modified bioactive peptides: recent advances, challenges and developments for medicinal chemistry.Peptides containing cyclin/Cdk-nuclear localization signal motifs derived from viral initiator proteins bind to DNA when unphosphorylatedTargeting folded RNA: a branched peptide boronic acid that binds to a large surface area of HIV-1 RRE RNAHIV-1 drug discovery: targeting folded RNA structures with branched peptides.Nuclear translocation as a novel target for anti-HIV drugs.Impact of Tat Genetic Variation on HIV-1 DiseaseRationally designed peptide regulators of protein kinase C.Strategies to inhibit viral protein nuclear import: HIV-1 as a target.Using peptides to study protein-protein interactions.Noncovalently associated cell-penetrating peptides for gene delivery applications.Cell penetration: scope and limitations by the application of cell-penetrating peptides.Review backbone N-modified peptides: How to meet the challenge of secondary amine acylation.Tuning the transport properties of HIV-1 Tat arginine-rich motif in living cells.Cell-penetrating, dimeric α-helical peptides: nanomolar inhibitors of HIV-1 transcription.An alpha-helical peptidomimetic inhibitor of the HIV-1 Rev-RRE interaction.Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.
P2860
Q24316120-987C119F-D819-4D24-9DA0-F9D297CD39B8Q30276963-43DCADBE-1846-4F01-84CC-99C6D93C966AQ33852418-251D2086-0842-421F-A191-EADC2BA475EFQ34360447-93C886D6-B5C1-495F-8E34-FB4086BFEACFQ34909697-9FC99BA5-4906-4135-BEAF-81F1996C6034Q35626292-F601B7F3-DBCD-4303-B46A-E1AD3908E536Q36066205-25DCDB56-905C-430B-A438-9440DA2A4A0AQ36148507-8E63BD98-15A9-4635-8DBE-12C0F645181BQ37271445-8249B5CD-9E03-4EF2-A662-5A2B8F8DA542Q37780819-CB94B513-540B-4631-8168-1E28B0E7F7F5Q37855887-579E209F-5263-44EC-A4C0-750392A64997Q38112173-E1C23B97-50C1-4EFA-9DFA-0AE08F40E966Q38238902-539C41CD-1308-422E-B831-DD02C8CAD4F2Q38533393-15FABD56-680A-46AC-B80F-97D8C435833BQ40027334-3FD45421-B779-4467-9516-5E76837854B1Q42204202-AB051546-7618-4494-9EE4-B4A1DF9717F4Q43196356-E2608A72-586C-4BA0-8EF8-64BAC37EF9E5Q53699625-A0725E62-FF3F-434C-BCF3-3E83D1265ACE
P2860
Development of a functional backbone cyclic mimetic of the HIV-1 Tat arginine-rich motif
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Development of a functional backbone cyclic mimetic of the HIV-1 Tat arginine-rich motif
@ast
Development of a functional backbone cyclic mimetic of the HIV-1 Tat arginine-rich motif
@en
Development of a functional backbone cyclic mimetic of the HIV-1 Tat arginine-rich motif
@nl
type
label
Development of a functional backbone cyclic mimetic of the HIV-1 Tat arginine-rich motif
@ast
Development of a functional backbone cyclic mimetic of the HIV-1 Tat arginine-rich motif
@en
Development of a functional backbone cyclic mimetic of the HIV-1 Tat arginine-rich motif
@nl
prefLabel
Development of a functional backbone cyclic mimetic of the HIV-1 Tat arginine-rich motif
@ast
Development of a functional backbone cyclic mimetic of the HIV-1 Tat arginine-rich motif
@en
Development of a functional backbone cyclic mimetic of the HIV-1 Tat arginine-rich motif
@nl
P2093
P2860
P356
P1476
Development of a functional backbone cyclic mimetic of the HIV-1 Tat arginine-rich motif
@en
P2093
P2860
P304
P356
10.1074/JBC.M002200200
P407
P577
2000-08-04T00:00:00Z